Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L Resnick

Showing results (201-210 of 207) with videos related to

Pageof 21
Sort By:
You have reached the last page of results.This site can display upto 207 results.
Clinical Journal of the American Society of Nephrology : CJASN|August 19, 2007
Renal provider recognition of symptoms in patients on maintenance hemodialysisSteven D Weisbord, Linda F Fried, Maria K Mor, et al.
Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology : Official Publication of the International Retrovirology Association|October 13, 1998
Phase I study of atevirdine mesylate (U-87201E) monotherapy in HIV-1-infected patientsL M Demeter, P M Meehan, G Morse, et al.
Rheumatology (Oxford, England)|April 4, 2017
Classification criteria for diffuse idiopathic skeletal hyperostosis: a lack of consensusJonneke S Kuperus, Erin E A de Gendt, F Cumhur Oner, et al.
Journal of Clinical Medicine|July 27, 2022
Health Problems in Adults with Prader-Willi Syndrome of Different Genetic Subtypes: Cohort Study, Meta-Analysis and Review of the LiteratureAnna G W Rosenberg, Charlotte M Wellink, Juan M Tellez Garcia, et al.
Biochemical Pharmacology|March 22, 1996
The benzylthio-pyrimidine U-31,355, a potent inhibitor of HIV-1 reverse transcriptaseI W Althaus, K C Chou, R J Lemay, et al.
British Journal of Pharmacology|June 6, 2007
Species-specific in vitro pharmacological effects of the cannabinoid receptor 2 (CB2) selective ligand AM1241 and its resolved enantiomersB Bingham, P G Jones, A J Uveges, et al.
Genes|July 2, 2021
The Diagnostic Journey of a Patient with Prader-Willi-Like Syndrome and a Unique Homozygous <i>SNURF-SNRPN</i> Variant; Bio-Molecular Analysis and Review of the LiteratureKarlijn Pellikaan, Geeske M van Woerden, Lotte Kleinendorst, et al.
Pageof 21

Showing results (201-210 of 207) with videos related to

Sort By:
Pageof 21
You have reached the last page of results.This site can display upto 207 results.
Clinical Journal of the American Society of Nephrology : CJASN|August 19, 2007
Renal provider recognition of symptoms in patients on maintenance hemodialysisSteven D Weisbord, Linda F Fried, Maria K Mor, et al.
Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology : Official Publication of the International Retrovirology Association|October 13, 1998
Phase I study of atevirdine mesylate (U-87201E) monotherapy in HIV-1-infected patientsL M Demeter, P M Meehan, G Morse, et al.
Rheumatology (Oxford, England)|April 4, 2017
Classification criteria for diffuse idiopathic skeletal hyperostosis: a lack of consensusJonneke S Kuperus, Erin E A de Gendt, F Cumhur Oner, et al.
Journal of Clinical Medicine|July 27, 2022
Health Problems in Adults with Prader-Willi Syndrome of Different Genetic Subtypes: Cohort Study, Meta-Analysis and Review of the LiteratureAnna G W Rosenberg, Charlotte M Wellink, Juan M Tellez Garcia, et al.
Biochemical Pharmacology|March 22, 1996
The benzylthio-pyrimidine U-31,355, a potent inhibitor of HIV-1 reverse transcriptaseI W Althaus, K C Chou, R J Lemay, et al.
British Journal of Pharmacology|June 6, 2007
Species-specific in vitro pharmacological effects of the cannabinoid receptor 2 (CB2) selective ligand AM1241 and its resolved enantiomersB Bingham, P G Jones, A J Uveges, et al.
Genes|July 2, 2021
The Diagnostic Journey of a Patient with Prader-Willi-Like Syndrome and a Unique Homozygous <i>SNURF-SNRPN</i> Variant; Bio-Molecular Analysis and Review of the LiteratureKarlijn Pellikaan, Geeske M van Woerden, Lotte Kleinendorst, et al.
Pageof 21